ANI Pharmaceuticals submits supplemental application for Oxycodone and Aspirin
ANI Pharmaceuticals has submitted a supplemental application for a combination product containing Oxycodone and Aspirin.
Therapeutic Area
Therapeutic area intelligence for Opioid Combination with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.